Merit Medical Systems Other Current Assets 2010-2025 | MMSI

Merit Medical Systems other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Merit Medical Systems other current assets for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Merit Medical Systems other current assets for 2024 were $0B, a 0% decline from 2023.
  • Merit Medical Systems other current assets for 2023 were $0B, a 0% decline from 2022.
  • Merit Medical Systems other current assets for 2022 were $0B, a 0% decline from 2021.
Merit Medical Systems Annual Other Current Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Merit Medical Systems Quarterly Other Current Assets
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.637B $1.357B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.591B 21.63
Becton Dickinson (BDX) United States $49.119B 12.16
Cardinal Health (CAH) United States $36.458B 19.09
Straumann Holding AG (SAUHY) Switzerland $20.442B 0.00
Labcorp (LH) United States $20.300B 16.47
Cooper (COO) United States $15.765B 20.91
West Pharmaceutical Services (WST) United States $14.771B 30.96
Align Technology (ALGN) United States $12.380B 24.58
Henry Schein (HSIC) United States $8.721B 14.96
DENTSPLY SIRONA (XRAY) United States $3.083B 9.21
CONMED (CNMD) United States $1.714B 12.82
STAAR Surgical (STAA) United States $0.925B 0.00
Lifevantage (LFVN) United States $0.159B 16.44
Pro-Dex (PDEX) United States $0.151B 16.51